ArticleBreast cancer research : BCR2005

Designing a HER2/neu promoter to drive alpha1,3galactosyltransferase expression for targeted anti-alphaGal antibody-mediated tumor cell killing.

Marion Lanteri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.